SEC ownership of NEPHROS INC

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001196298.

Comparable stake leader

Charles E. Davidson

Disclosed value leader

Topline Capital Management, LLC

Comparable rows

3/35

Latest evidence

09 Nov 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
3 of 35
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Charles E. Davidson
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
09 Nov 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001196298
Issuer location
South Orange, NJ

Ownership snapshot

Top shareholders of NEPHROS INC (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Charles E. Davidson
Disclosed value leader
Topline Capital Managemen...
Comparable rows
3/35
Latest evidence
09 Nov 2026
13D/G 3/4/5 13F Lead comparable stake: 5.7% 32 rows are not safely comparable across share classes. 13D/G row: Charles E. Davidson Showing 1-8 of 35 holder rows.

Quick read

Charles E. Davidson leads the comparable SEC ownership view at 5.7%.

3 of 35 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Charles E. Davidson's linked filing trail.
Comparable ownership Top 3
Charles E. Davidson 5.7%
Topline Capital Management, LLC 5.6%
WEXFORD CAPITAL LP 2.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 35 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Charles E. Davidson
13D/G 3/4/5
10%+ Owner
5.7%
Reported 13D/G · 14 Sep 2026
$2,807,100
616,945 shares
$0 14 Sep 2026
Topline Capital Management, LLC
13D/G
5.6%
Reported 13D/G · 04 Aug 2025
$2,815,930
595,334 shares
$0 04 Aug 2025
WEXFORD CAPITAL LP
13D/G 3/4/5 13F
10%+ Owner · Company
2.1%
Reported 13D/G · 14 Sep 2026
$1,017,102
223,539 shares
$0 14 Sep 2026
Joseph Jacobs
3/4/5
10%+ Owner
—
mixed-class rows
$798,034
259,737 shares
mixed-class rows
— 14 Sep 2026
Wexford GP LLC
3/4/5
10%+ Owner
—
mixed-class rows
$798,034
259,737 shares
mixed-class rows
— 14 Sep 2026
Robert R. Banks Jr.
3/4/5
President and CEO
—
mixed-class rows
$1,880,603
427,165 shares
mixed-class rows
— 23 Mar 2026
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
13F
Company
13F
—
denominator unverified
$1,286,676
346,813 shares
— 30 Sep 2026
Arthur H. Amron
3/4/5
Director
—
mixed-class rows
$813,657
220,279 shares
mixed-class rows
— 09 Nov 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 16 Nov 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-16 of 16 reporting-owner rows connected to NEPHROS INC. Open a relationship link for the CIK-to-CIK filing trail.

Rows
16
Largest Forms 3/4/5 holder
Robert R. Banks Jr.
Net 12M change
$0
Latest report
09 Nov 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Robert R. Banks Jr. President and CEO $1,880,603 Mixed 23 Mar 2026
Arthur H. Amron Director $813,657 Mixed 09 Nov 2026
Charles E. Davidson 10%+ Owner $798,034 Mixed 14 Sep 2026
Wexford GP LLC 10%+ Owner $798,034 Mixed 14 Sep 2026
Joseph Jacobs 10%+ Owner $798,034 Mixed 14 Sep 2026
WEXFORD CAPITAL LP 10%+ Owner $798,034 Mixed 14 Sep 2026
Amron Holdings LLC Director $657,483 Mixed 14 Sep 2026
Judy Krandel Power Chief Financial Officer $551,766 Mixed 23 Mar 2026
Oliver Spandow Power Director $496,571 Mixed 09 Nov 2026
Daron Evans CEO Specialty Renal Products $351,795 Mixed 24 May 2021
Andrew Astor Power President, CEO & CFO, Director $204,342 Mixed 05 Mar 2022
Alisa Lask Director $109,167 Mixed 01 Jan 2025
Tom Gwydir Power Director $95,210 Mixed 05 Jan 2023
Wesley S. Lobo Chief Marketing Officer $77,461 Mixed 16 Feb 2022
Lisa Nettis Power Director $70,245 Mixed 10 Nov 2025
Joseph Michael Harris Director $39,719 Mixed 01 Jan 2025

Recent insider transactions for NEPHROS INC

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Oliver Spandow Power NEPH Common Stock Award 3.19% 3,916 126,797 09 Nov 2026 Direct
Arthur H. Amron NEPH Common Stock Award 2.22% 3,514 162,137 09 Nov 2026 Direct
WEXFORD CAPITAL LP NEPH Common Stock Other -95.3% -3,377,821 166,667 14 Sep 2026 See footnotes
WEXFORD CAPITAL LP NEPH Common Stock Other -95.3% -3,377,821 166,667 14 Sep 2026 See footnotes
Wexford Capital Lp NEPH Common Stock Other -95.3% -3,377,821 166,667 14 Sep 2026 See footnotes
Wexford Capital Lp NEPH Common Stock Other -95.3% -3,377,821 166,667 14 Sep 2026 See footnotes
Amron Arthur H NEPH Common Stock Other 25,546 25,546 14 Sep 2026 See footnote
Arthur H. Amron NEPH Common Stock Other 25,546 25,546 14 Sep 2026 See footnote
Amron Arthur H NEPH Common Stock Other 12.6% 17,749 158,623 14 Sep 2026 Direct
Arthur H. Amron NEPH Common Stock Other 12.6% 17,749 158,623 14 Sep 2026 Direct
WEXFORD CAPITAL LP NEPH Common Stock Options Exercise 1.45% 812 56,872 18 Aug 2026 Direct
WEXFORD CAPITAL LP NEPH Common Stock Options Exercise 1.45% 812 56,872 18 Aug 2026 Direct
Wexford Capital Lp NEPH Common Stock Options Exercise 1.45% 812 56,872 18 Aug 2026 Direct
Wexford Capital Lp NEPH Common Stock Options Exercise 1.45% 812 56,872 18 Aug 2026 Direct
WEXFORD CAPITAL LP NEPH Stock Option (Right to Buy) Options Exercise -9.42% -3,765 36,198 18 Aug 2026 Direct
WEXFORD CAPITAL LP NEPH Stock Option (Right to Buy) Options Exercise -9.42% -3,765 36,198 18 Aug 2026 Direct
Wexford Capital Lp NEPH Stock Option (Right to Buy) Options Exercise -9.42% -3,765 36,198 18 Aug 2026 Direct
Wexford Capital Lp NEPH Stock Option (Right to Buy) Options Exercise -9.42% -3,765 36,198 18 Aug 2026 Direct
Arthur H. Amron NEPH Common Stock Award 1.75% 2,418 140,874 12 Aug 2026 Direct
Arthur H. Amron NEPH Common Stock Award 2.65% 3,574 138,456 11 May 2026 Direct
Robert R. Banks Jr. NEPH Common Stock Options Exercise 171.4% 120,000 190,000 23 Mar 2026 Direct
Robert R. Banks Jr. NEPH Stock Option (right to buy) Options Exercise -33.6% -120,000 237,165 23 Mar 2026 Direct
Judy Krandel Power NEPH Common Stock Options Exercise 68,861 68,861 23 Mar 2026 Direct
Judy Krandel Power NEPH Stock Option (right to buy) Options Exercise -56.2% -68,861 53,663 23 Mar 2026 Direct
Arthur H. Amron NEPH Common Stock Award 2.75% 3,610 134,882 16 Mar 2026 Direct
Judy Krandel Power NEPH Stock Option (right to buy) Award 4,000 4,000 16 Mar 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .